This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

September 9, 2021
Delivered DigitallyUS Eastern Daylight Time

Aevum Therapeutics

Profile

Aevum Therapeutics is dedicated to the development of drugs treating neurodegenerative disorders. It has long been shown that exercise slows cognitive decline and reduces the risk for dementia along with many other health benefits. Thus, we strongly believe that harbors untapped potential for therapeutic discovery and are developing irisin, an exercise-induced peptide with strong neuroprotective effects, as our flagship therapeutic for the treatment of Alzheimer’s, Parkinson’s, and ALS.